VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, has published a company update presentation designed to complement remarks that will be provided by management at 3:00 p.m. PT (6:00 p.m. ET) today, Jan. 9, 2023, during the 41st Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation provides an overview of the Company’s recent performance and achievements, and offers insight into future goals and catalysts for 2023 and beyond.
The presentation is available on the Investor Relations page of the Bausch + Lomb website at: https://ir.bausch.com/investors/events-presentations. A live webcast and audio archive of the event will also be available on the Investor Relations page of the Company’s web site.
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.
Contacts
Investor:
Arthur Shannon
[email protected]
Allison Ryan
[email protected]
(877) 354-3705 (toll free)
Media:
Lainie Keller
[email protected]
(908) 927-1198
Kristy Marks
[email protected]
(908) 927-0683
